SE8901342D0 - Biological materials, processes for producing biological materials and for using such materials in therapy - Google Patents

Biological materials, processes for producing biological materials and for using such materials in therapy

Info

Publication number
SE8901342D0
SE8901342D0 SE8901342A SE8901342A SE8901342D0 SE 8901342 D0 SE8901342 D0 SE 8901342D0 SE 8901342 A SE8901342 A SE 8901342A SE 8901342 A SE8901342 A SE 8901342A SE 8901342 D0 SE8901342 D0 SE 8901342D0
Authority
SE
Sweden
Prior art keywords
materials
inhs
processes
biological materials
producing
Prior art date
Application number
SE8901342A
Other languages
English (en)
Swedish (sv)
Other versions
SE8901342L (sv
Inventor
J-M Dayer
Original Assignee
Biogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22218720&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE8901342(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biogen Inc filed Critical Biogen Inc
Publication of SE8901342L publication Critical patent/SE8901342L/
Publication of SE8901342D0 publication Critical patent/SE8901342D0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyridine Compounds (AREA)
SE8901342A 1987-08-26 1989-04-13 Biological materials, processes for producing biological materials and for using such materials in therapy SE8901342D0 (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8963287A 1987-08-26 1987-08-26
PCT/US1988/002819 WO1989001946A1 (en) 1987-08-26 1988-08-17 Biological materials, processes for producing biological materials and for using such materials in therapy

Publications (2)

Publication Number Publication Date
SE8901342L SE8901342L (sv) 1989-04-13
SE8901342D0 true SE8901342D0 (sv) 1989-04-13

Family

ID=22218720

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8901342A SE8901342D0 (sv) 1987-08-26 1989-04-13 Biological materials, processes for producing biological materials and for using such materials in therapy

Country Status (20)

Country Link
EP (1) EP0341273B1 (ja)
JP (2) JP3014099B2 (ja)
KR (2) KR0138919B1 (ja)
AT (1) ATE147408T1 (ja)
AU (1) AU633471B2 (ja)
BE (1) BE1002375A3 (ja)
CA (1) CA1341026C (ja)
DE (1) DE3855747T2 (ja)
DK (1) DK175837B1 (ja)
ES (3) ES2015348A6 (ja)
FR (1) FR2621821A1 (ja)
GB (1) GB2220662A (ja)
HK (1) HK1007748A1 (ja)
IL (1) IL87543A0 (ja)
IT (1) IT1226855B (ja)
NL (1) NL8820676A (ja)
NZ (1) NZ225940A (ja)
SE (1) SE8901342D0 (ja)
WO (1) WO1989001946A1 (ja)
ZA (1) ZA886251B (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5075222A (en) * 1988-05-27 1991-12-24 Synergen, Inc. Interleukin-1 inhibitors
US6159460A (en) * 1988-05-27 2000-12-12 Amgen Inc. Method for treating interleukin-1 mediated diseases
KR0148009B1 (ko) * 1988-05-27 1998-08-01 그래고리 비. 아보트 인터루킨-1 억제제
JP3192651B2 (ja) * 1988-05-27 2001-07-30 アムジェン，インコーポレーテッド インターロイキン―１インヒビター
US6858409B1 (en) 1988-05-27 2005-02-22 Amgen Inc. Nucleic acids encoding interleukin-1 inhibitors and processes for preparing interleukin-1 inhibitors
AU651955B2 (en) * 1989-11-29 1994-08-11 Amgen, Inc. Production of recombinant human interleukin-1 inhibitor
US5714140A (en) * 1989-12-13 1998-02-03 Otsuka Pharmaceutical Co., Ltd. Method for inhibiting the production of bioactive IL-1 by administering M-CSF
US6552170B1 (en) 1990-04-06 2003-04-22 Amgen Inc. PEGylation reagents and compounds formed therewith
WO1991017184A1 (en) * 1990-04-27 1991-11-14 The Upjohn Company Modified interleukin-1 inhibitors
WO1991017249A1 (en) * 1990-05-01 1991-11-14 Cetus Corporation Interleukin-1 antagonist and uses thereof
WO1997009984A1 (en) * 1995-09-13 1997-03-20 Takeda Chemical Industries, Ltd. Immunosuppressant
US6294170B1 (en) 1997-08-08 2001-09-25 Amgen Inc. Composition and method for treating inflammatory diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4992367A (en) * 1986-05-12 1991-02-12 Hoffmann-La Roche Inc. Enhanced expression of human interleukin-2 in mammalian cells

Also Published As

Publication number Publication date
IT8821743A0 (it) 1988-08-25
DE3855747D1 (de) 1997-02-20
NL8820676A (nl) 1989-07-03
IL87543A0 (en) 1989-01-31
NZ225940A (en) 1992-06-25
EP0341273B1 (en) 1997-01-08
JP3217752B2 (ja) 2001-10-15
KR0138919B1 (ko) 1998-04-30
FR2621821A1 (fr) 1989-04-21
DK203189A (da) 1989-04-26
JPH10327862A (ja) 1998-12-15
SE8901342L (sv) 1989-04-13
ATE147408T1 (de) 1997-01-15
JP3014099B2 (ja) 2000-02-28
AU2427288A (en) 1989-03-31
ZA886251B (en) 1990-04-25
KR890701629A (ko) 1989-12-21
JPH02500643A (ja) 1990-03-08
HK1007748A1 (en) 1999-04-23
ES2017275A6 (es) 1991-01-16
KR0138654B1 (ko) 1998-04-30
EP0341273A4 (en) 1990-09-19
DK203189D0 (da) 1989-04-26
DK175837B1 (da) 2005-03-21
IT1226855B (it) 1991-02-19
DE3855747T2 (de) 1997-06-12
WO1989001946A1 (en) 1989-03-09
BE1002375A3 (fr) 1991-01-22
GB2220662A (en) 1990-01-17
GB8912533D0 (en) 1989-08-02
EP0341273A1 (en) 1989-11-15
ES2015348A6 (es) 1990-08-16
AU633471B2 (en) 1993-02-04
CA1341026C (en) 2000-06-13
ES2017274A6 (es) 1991-01-16

Similar Documents

Publication Publication Date Title
ATE113295T1 (de) Tumornekrosefaktor, verfahren zu seiner herstellung, denselben enthaltende zusammensetzungen, dafür kodierende dns und diese dns verwendendes testverfahren.
BR9408025A (pt) Compostos de peptidila e seu uso terapêutico como inibidores de metaloproteinases
DK0398327T4 (da) Tumornekrosefaktor-bindende protein, dets oprensning og antistoffer dertil
MY101852A (en) Tumor necrosis factor, methods for its preparation, containing it, dna encoding it and assay method using such dna.
ATE169337T1 (de) Rekombinante expressionsvektoren und reinigungsverfahren für dns-polymerase aus thermus thermophilus
SE8901342D0 (sv) Biological materials, processes for producing biological materials and for using such materials in therapy
HUP9901874A2 (hu) Humán TNFalfa-t kötő antitestek
EA200001124A1 (ru) Способ генной терапии
ATE385517T1 (de) Interferon ähnliche moleküle, und deren verwendungen
ATE159032T1 (de) Anti-hiv protein, tap-29, aus trichosanthes, seine kodierende dna und therapeutischen anwendungen

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8901342-9

Effective date: 19901007